Digital Building and training AI models for pharmacovigilance There’s no escaping the rise of AI adoption and integration. It’s not so much a question of whether you will adopt AI into your business practices, but how.
R&D The 3 biggest mistakes we keep making in clinical operations The life sciences industry is notoriously slow to change – for good reason, as there’s significantly more at stake than in other industries.
R&D Now is the time for pharma to help solve bias in clinical tr... Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.